{"id":"W7108620632","doi":"10.1182/blood-2025-5120","title":"Toxicities on the E1910 phase III randomized trial of blinatumomab plus chemotherapy in adults with BCR:ABL-1 negative acute lymphoblastic leukemia","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Blinatumomab; Chemotherapy; Minimal residual disease; Acute lymphocytic leukemia; Incidence (geometry); Toxicity; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001681171,0.001367124,0.001267332,0.0003371424,0.0003743907,0.0007640283,0.0008611419,0.0010078,0.005808191],"category_scores_gemma":[0.001159232,0.0003689676,0.0009354901,0.0004060784,0.0005377764,0.0005958339,0.0003401497,0.002751656,0.0006800295],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009523942,"about_ca_system_score_gemma":0.00110566,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007228543,"about_ca_topic_score_gemma":0.003212329,"domain_scores_codex":[0.9993621,0.0004285651,0.00003321108,0.00005083304,0.00005964481,0.00006566394],"domain_scores_gemma":[0.9992575,0.0002280631,0.0002395713,0.00003161068,0.00003467062,0.0002085965],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8907951,0.02094052,0.00459922,0.001338816,0.001232764,0.0002150587,0.0001032567,0.001236642,0.009775196,0.0005143721,0.007688483,0.06156052],"study_design_scores_gemma":[0.8414195,0.1431602,0.006980616,0.0001181068,0.0006233467,0.0001994832,0.00003315243,0.001006933,0.002022226,0.0003300947,0.004084146,0.0000221592],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9795608,0.005286616,0.0006266829,0.001024376,0.0003464838,0.005140596,0.002422771,0.00009679951,0.005494978],"genre_scores_gemma":[0.9698622,0.004966359,0.003039408,0.00269337,0.0003299028,0.006901175,0.003723233,0.00005267042,0.008431637],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005808191,"threshold_uncertainty_score":0.0194304,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008506622467973221,"score_gpt":0.281102103651251,"score_spread":0.2725954811832778,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}